Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

UNITED THERAPEUTICS (UTHR) FCF Margin: 2009-2024

Historic FCF Margin for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to 37.55%.

  • UNITED THERAPEUTICS's FCF Margin rose 383.00% to 43.98% in Q3 2025 from the same period last year, while for Sep 2025 it was 47.05%, marking a year-over-year increase of 1446.00%. This contributed to the annual value of 37.55% for FY2024, which is 543.00% up from last year.
  • UNITED THERAPEUTICS's FCF Margin amounted to 37.55% in FY2024, which was up 16.92% from 32.12% recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's FCF Margin registered a high of 46.95% during FY2020, and its lowest value of 28.32% during FY2021.
  • Its 3-year average for FCF Margin is 34.65%, with a median of 34.28% in 2022.
  • Its FCF Margin has fluctuated over the past 5 years, first spiked by 6,699bps in 2020, then slumped by 1,863bps in 2021.
  • Over the past 5 years, UNITED THERAPEUTICS's FCF Margin (Yearly) stood at 46.95% in 2020, then tumbled by 1,863bps to 28.32% in 2021, then surged by 595bps to 34.28% in 2022, then plummeted by 216bps to 32.12% in 2023, then spiked by 543bps to 37.55% in 2024.